Fewer iNOS+ M1 macrophages are detected in the G sample, while an increased presence of CD163 + M2 macrophages is observed at the implant-tissue interface in the G scaffold group compared to the BCC group, both at 3 days and 1 month. Here, CD163 is linked to skin basal cell carcinoma.